Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

Condition:   Schizophrenia Interventions:   Drug: MK-8189;   Drug: Risperidone;   Drug: Placebo to MK-8189;   Drug: Placebo to risperidone Sponsor:   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials